NFKB1 and metabolic dysfunction-associated steatohepatitis: Inhibition of NF-κB-regulated inflammatory response, suppression of AMPK-mediated lipid/triglyceride accumulation, and enhancement of Nrf2 antioxidant defense system might contribute to the effect of chicoric acid against NASH and fibrosis [227].